Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2012 | 03-2012 | 12-2011 | |
| Sales | 3,040,400 | 0 | 0 |
| Cost of Goods | 917,930 | N/A | N/A |
| Gross Profit | 2,122,460 | N/A | N/A |
| Operating Expenses | 1,462,240 | 0 | 0 |
| Operating Income | 661,160 | N/A | N/A |
| Other Income | -64,980 | 0 | 0 |
| Pre-tax Income | 596,180 | 0 | 0 |
| Income Tax | 152,570 | N/A | N/A |
| Net Income Continuous | 443,610 | N/A | N/A |
| Net Income | $443,610 | $N/A | $N/A |
| EBITDA(a) | $661,160 | $N/A | $N/A |